Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Feb 16, 2016

Total Value: $1.04B (99.5% shares, 0.5% debt)

Holdings (14)

— OPHTHOTECH CORP 37.1%

Value $386M Shares 4,910,487 Share Price $78.53 Est. Cost/Share $32.35 Unrealized @ Report Date —

VTI VANGUARD INDEX FDS 29.9%

Value $311M Shares 2,979,100 Share Price $104.30 Est. Cost/Share $57.39 Unrealized @ Report Date —

INGN INOGEN INC 13.7%

Value $142M Shares 3,549,320 Share Price $40.09 * Est. Cost/Share $17.78 Unrealized @ Report Date +137.8%

VGK VANGUARD INTL EQUITY INDEX F 10.1%

Value $105M Shares 2,101,000 Share Price $49.88 Est. Cost/Share $45.01 Unrealized @ Report Date —

— COLUCID PHARMACEUTICALS INC 2.5%

Value $25.58M Shares 3,056,563 Share Price $8.37 Est. Cost/Share $8.90 Unrealized @ Report Date —

— TOBIRA THERAPEUTICS INC 2.4%

Value $24.84M Shares 2,471,405 Share Price $10.05 Est. Cost/Share $17.25 Unrealized @ Report Date —

PEN PENUMBRA, INC. 1.2%

Value $12.71M Shares 236,144 Share Price $53.81 * Est. Cost/Share $43.14 Unrealized @ Report Date +5.0%

— NABRIVA THERAPEUTICS AG 0.8%

Value $8.417M Shares 874,985 Share Price $9.62 Est. Cost/Share $9.50 Unrealized @ Report Date —

— INVUITY INC 0.8%

Value $8.158M Shares 925,000 Share Price $8.82 Est. Cost/Share $8.82 Unrealized @ Report Date —

— HTG MOLECULAR DIAGNOSTICS INC 0.5%

Value $5.582M Shares 1,280,185 Share Price $4.36 Est. Cost/Share $11.15 Unrealized @ Report Date —

— WRIGHT MEDICAL GROUP 0.5%

Value $4.714M Shares 4,622,032 Share Price $1.02 Est. Cost/Share $2.50 Unrealized @ Report Date —

— TOKAI PHARMACEUTICALS INC 0.4%

Value $4.107M Shares 470,946 Share Price $8.72 Est. Cost/Share $14.41 Unrealized @ Report Date —

GKOS GLAUKOS CORP 0.2%

Value $1.852M Shares 75,000 Share Price $24.69 * Est. Cost/Share $29.05 Unrealized @ Report Date -21.0%

XENE XENON PHARMACEUTICALS INC 0.1%

Value $1.026M Shares 127,563 Share Price $8.04 * Est. Cost/Share $14.68 Unrealized @ Report Date -41.6%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	OPHTHOTECH CORP	4,910,487	$386M	37.1%	$78.53	$32.35	—	COM	683745103
VTI	VANGUARD INDEX FDS	2,979,100	$311M	29.9%	$104.30	$57.39	—	TOTAL STK MKT	922908769
INGN	INOGEN INC	3,549,320	$142M	13.7%	$40.09 *	$17.78	+137.8%	COM	45780L104
VGK	VANGUARD INTL EQUITY INDEX F	2,101,000	$105M	10.1%	$49.88	$45.01	—	FTSE EUROPE ETF	922042874
—	COLUCID PHARMACEUTICALS INC	3,056,563	$25.58M	2.5%	$8.37	$8.90	—	COM	19716T101
—	TOBIRA THERAPEUTICS INC	2,471,405	$24.84M	2.4%	$10.05	$17.25	—	COM	88883P101
PEN	PENUMBRA, INC.	236,144	$12.71M	1.2%	$53.81 *	$43.14	+5.0%	COM	70975L107
—	NABRIVA THERAPEUTICS AG	874,985	$8.417M	0.8%	$9.62	$9.50	—	COM	62957M104
—	INVUITY INC	925,000	$8.158M	0.8%	$8.82	$8.82	—	COM	46187J205
—	HTG MOLECULAR DIAGNOSTICS INC	1,280,185	$5.582M	0.5%	$4.36	$11.15	—	COM	40434H104
—	WRIGHT MEDICAL GROUP	4,622,032	$4.714M	0.5%	$1.02	$2.50	—	CONTINGENT VALUE RIGHTS	98235T115
—	TOKAI PHARMACEUTICALS INC	470,946	$4.107M	0.4%	$8.72	$14.41	—	COM	88907J107
GKOS	GLAUKOS CORP	75,000	$1.852M	0.2%	$24.69 *	$29.05	-21.0%	COM	377322102
XENE	XENON PHARMACEUTICALS INC	127,563	$1.026M	0.1%	$8.04 *	$14.68	-41.6%	COM	98420N105